The management of BPH suggests that alpha blockers alfuzosin, doxazosin, tamsulosin, and terazosin are appropriate and effective treatment options for men with bothersome LUTS/BPH.
Lower urinary tract symptoms (LUTS) occur in men and women increasingly with age. In men, LUTS is often concurrent with benign prostatic hyperplasia (BPH). BPH is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostate. The progression of BPH can lead to benign prostatic enlargement (BPE). Men with LUTS secondary to BPH (LUTS/BPH) tend to seek medical attention after symptoms have become disruptive to their quality of life (QoL).
The American Urological Association (AUA) guideline on the management of BPH suggests that alpha blockers alfuzosin, doxazosin, tamsulosin, and terazosin are appropriate and effective treatment options for men with bothersome LUTS/BPH. Efficacy and safety of these medications is supported by several systematic reviews.
In addition to conservative management，minimally invasive surgery or traditional surgical approaches also the treatment that many people choose.For instance,TURP、HoLEP、Open prostatectomy、Photoselective vaporisation of the prostate (PVP).
